Molecular Partners Ag (MOLN) Current Deferred Revenue (2020 - 2024)

Molecular Partners Ag (MOLN) has reported Current Deferred Revenue for 5 consecutive years, with $646889.2 the latest figure, recorded in Q2 2024.

• Quarterly Current Deferred Revenue fell 90.04% year-over-year to $646889.2 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $646889.2 (down 90.04% YoY) and the FY2023 annual result came in at $4.9 million, down 53.16% from the prior year.
• Current Deferred Revenue grew to $646889.2 in Q2 2024 per MOLN's latest filing, from $2183.7 in the prior quarter.
• Over the last five years, Current Deferred Revenue for MOLN reached as high as $50.8 million in Q4 2020 and fell as low as $2183.7 in Q1 2024.
• A 5-year average of $9.3 million and a median of $646889.2 in 2024 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2021 — Current Deferred Revenue fell 24.71% — and 2024, when it plunged 90.04%.
• Year by year, Current Deferred Revenue stood at $50.8 million in 2020, then declined by 24.71% to $38.2 million in 2021, then tumbled by 72.71% to $10.4 million in 2022, then sank by 53.16% to $4.9 million in 2023, then tumbled by 86.76% to $646889.2 in 2024.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $646889.2, $2183.7, and $4.9 million for Q2 2024, Q1 2024, and Q4 2023 respectively.